Characterization of an antagonistic peptide produced by a Bacteroides Fragilis isolate obtained from a patient with intra-abdominal infection / Caracterização de um peptido antagonístico produzido por Bacteroides Fragilis isolado obtido em um paciente com infecção intra-abdominal
DOI:
https://doi.org/10.34117/bjdv5n12-303Keywords:
Bacteroides, Parabacteroides, antagonistic substance, intra-abdominal infection.Abstract
The indigenous microbiota of humans is extremely rich and diverse, with special emphasis on the intestinal microbiota. As a constituent of this microbiota, it is mentioned the genus Bacteroides, whose members are Gram negative rods, obligate anaerobes, amphibionts, associated to the etiopathogenesis of important infectious diseases, such as intra-abdominal infections. Bacteroides strains have the ability to synthesize antagonistic substances that play an ecological role, especially in densely colonized habitats, giving a competitive advantage to the producing samples. The objective of this study was to evaluate the synthesis capacity of antagonistic substances by 40 samples of Bacteroides and Parabacteroides isolated from patients with intra-abdominal infections. The expression of antagonism was evaluated by the overlay diffusion method, using, as well as the test samples, 36 reference samples of Gram negative and Gram-positive bacteria. Subsequently, a production strain (Bacteroides fragilis) was used for extraction, purification and partial characterization of the detected antagonistic substance. As indicator strains, Bacteroides ovatus and Bacteroides caccae were used. The production strain was submitted to protein extraction, and the activity of the precipitated intracellular extract was detected with (NH4) 2SO4 in concentrations of 30% (C30) and 50% (C50). C30 and C50 were inactivated by proteases and high temperatures and remained active after exposure to organic solvents and a wide pH range. Both fractions presented antagonistic activity of bacteriostatic nature. The C50 extract was subjected to ion exchange chromatography, and 50 fractions were recovered. Among them, fractions 1 to 4, referring to a single peak, that were not able to bind to the column, presented antagonistic activity. Fractions from the ion exchange chromatography were applied in gel filtration chromatography. Among them, fractions 2 and 3 were able to inhibit the developing sample. These fractions were submitted to reverse phase chromatography, and 50 fractions were collected. One of them, fraction 2C, remained active against the revealing sample. Mass spectrometry, from fraction 2C obtained from reverse phase chromatography, presented ions of approximately 1300.00 Da, which generated a more intense signal. The search performed by similarity between the sequenced peptides and proteins described in the BLASTP database, from fragmentation obtained in reverse phase chromatography, resulted in 100% identity between two peptides. One of the sequenced peptides showed 100% identity to a type VII secretion protein. The search performed by similarity between the sequenced peptides and proteins described in the ANTIMICROBIAL PEPTIDE DATABASE database, from fragmentation obtained with trypsin digestion, resulted in 42% identity with a Streptomyces microcine. Together, the results indicate the production of antagonistic substances by the B. fragilis sample under study. It is plausible to assume that they play a relevant role in interbacterial relationships, as a virulence factor, in a complex environment such as intra-abdominal infection.
References
APOLÔNIO, A. C. M.; CARVALHO, M. A. R.; BEMQUERER, M. P.; SANTORO, M. M.; PINTO, S. Q.; OLIVEIRA, J. S.; SANTOS, K. V.; FARIAS, L. M. Purification and partial characterization of a bacteriocin produced by Eikenella corrodens. Journal of Applied of Microbiology, v. 104, p. 508 - 514, 2008.
AVELAR, K. E. S.; PINTO, L. J. F.; LOBO, L. A.; BASTOS, M. C. F.; DOMINGUES, R. M. C. P.; FERREIRA, M. C. Production of bacteriocin by Bacteroides fragilis and partial characterization. Letters in Applied Microbiology, v. 29, p. 264 - 268, 1999.
BEERENS, E. L.; BARON, G. Demonstration of bacteriocins elaborated by anaerobic gram negative bacteria belonging to the Eggerthella genus. Annales Institut Pasteur Paris, v. 108, p. 255 - 256, 1965.
BOOTH, S. J.; JOHNSON, J. L.; WILKINS, T. D. Bacteriocin production by strains of Bacteroides isolated from human feces and the role of theses strains in the bacterial ecology of the colon. Antimicrobial Agents and Chemotherapy, v. 11, p. 718 - 724, 1977.
BRITTON, H. T. S.; ROBINSON, R. A. Journal of the Chemical Society, 1931.
CAO, Y.; ROCHA, E. R. ; JEFFREY, C. S. Efficient utilization of complex n-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections. Proceedings of the National Academy of Sciences, v. 111, p. 12901 - 12906, 2014.
CASCALES, E.; BUCHANAN, S. K.; DUCHE, D.; KLEANTHOUS, C.; LLOUBES, R.; POSTLE, K.; RILEY, M.; SLATIN, S.; CAVARD, D. Colicin biology. Microbiology and Molecular Biology Reviews, v. 71, p.158 - 229, 2007.
CLINICAL AND LABORATORY STANDARDS INSTITUTE.CLINICAL AND LABORATORY STANDARDS INSTITUTE. Methods for dilution antimicrobial susceptibility testing of anaerobic bacteria. Approved Standard - Seventh Edition, v. 27 (2). CLSI document M11-A7 (ISBN 1-56238-626-3). CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA, 2012.
COTTER, P. D. An ‘Upp’-turn in bacteriocin receptor identification. Molecular Microbiology, v. 92, p.1159 - 1163, 2014.
COYNE, M. J.; ROELOFS, K. G.; COMSTOCK, L. E. Type VI secretion systems of human gut Bacteroidales segregate into three genetic architectures, two of which are contained on mobile genetic elements. BMC Genomics, v. 17, p. 1 - 21, 2016.
DINIZ, C. G.; CARA, D. C.; NICOLI, J. R.; FARIAS, L. M.; DE CARVALHO, M. A. R. Effect of metronidazole on the pathogenicity of resistant Bacteroides strains in gnotobiotic mice. Antimicrobial Agents and Chemotherapy, v. 44, p. 2419 - 2423, 2000.
FARIAS, L. M.; CARVALHO, M. A. R.; DAMASCENO, C. A. V.; CISALPINO, E.O.; VIEIRA, E. C. Bacteriocin-like Activity of Bacteroides fragilis group isolated from marmosets. Research in Microbiology, v.143, p.151 - 59, 1992.
FARIAS, L. M.; TOTOLA, A. H.; MIRANDA, C. M. S.; CARVALHO, M. A. R.; DAMASCENO, C. A. V.; TAVARES, C. A. P.; CISALPINO, E. O.; VIEIRA, E. C. Extraction, partial purification and characterization of a bacteriocin (fragilicin) produced by a strain of Bacteroides fragilis isolated from Callithrix penicillata. Research in Microbiology, v. 145, p. 9 - 16, 1994.
GREEN, A. A.; HUGES, W. Protein fractionation on the basis of solubility in aqueous solutions of salts and organic solvents. Methods in Enzymology, v.1, p. 67 - 90, 1955.
HAMADA, S.; OOSHIMA, T. Production and properties of bacteriocins (mutacins) from Streptococcus mutans. Archives of Oral Biology, v. 20, p. 641 - 648, 1975.
HAVLIS, J. et al. Fast-response proteomics by accelerated in-gel digestion of proteins. Analytical Chemistry., v. 75, p. 1300 - 1306, 2003.
HAYES, T. J.; CUNDY, K. R.; FERNANDES, P. B.; HOOBER, J. K. Purification and characterization of a bacteriocin from Bacteroides fragilis. Journal of Bacteriology, v. 155, p. 1171 - 1177, 1983.
ISHIKAWA, E. ; MATSUKI, T.; KUBOTA, H.; MAKINO, H.; SAKAI, T.; OISHI, K.; KUSHIRO, A.; FUJIMOTO, J.; WATANABE, K.; WATANUKI, M.; TANAKA, R. Ethnic diversity of gut microbiota: species characterization of Bacteroides fragilis group and genus Bifidobacterium in healthy Belgian adults, and comparison with data from Japanese subjects. Journal of Bioscience and Bioengineering, v. 116, p. 265 - 270, 2013.
LEVISON, M. E.; LEVISON, J. H. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infectious Disease Clinics of North America, v. 23, p. 791 - 815, 2009.
LOBO, L. A.; BENJAMIM, C. F; OLIVEIRA A. C. The interplay between microbiota and inflammation: lessons from peritonitis and sepsis. Clinical & Translational Immunology, v. 5, p. 1 - 8, 2016.
MACFARLAND, L. V. Normal flora: diversity and functions. Microbial Ecology in Health and Disease, v. 12, p.193 - 207, 2000.
MAJEED, H.; LAMPERT, A.; GHAZARYAN, L.; GILLOR, O. The Weak Shall Inherit: Bacteriocin-mediated interactions in bacterial populations. PLoS ONE, v. 8, p. 6383 - 6387, 2013.
MICHEL-BRIAND, Y.; BAYSSE, C. The pyocins of Pseudomonas aeruginosa. Biochimie, v. 84, p. 499 - 510, 2002.
MIRANDA, C. M.; FARIAS, L. M.; CARVALHO, M. A.; DAMASCENO, C. A.; TOTOLA, A. H.; TAVARES, C. A.; CISALPINO, E. O.; VIEIRA, C. E. Purification and partial characterization of a bacteriocin isolated from Bacteroides ovatus H47. Canadian Journal of Microbiology, v. 39, p. 169 - 174, 1993.
MOSSIE, K. G.; JONES, D. T.; ROBB, F. T.; WOODS, D. R. Characterization and mode of action of a bacteriocin produced by a Bacteroides fragilis strain. Antimicrobial Agents and Chemotherapy, v. 16, p. 724 - 730, 1979.
MOSSIE, K. G.; JONES, D. T.; ROBB, F. T.; WOODS, D. R. Inibition of ribonucleic acid polymerase by a bacteriocin from Bacteroides fragilis. Antimicrobial Agents and Chemotherapy, v. 20, p. 437 - 442, 1981.
NAKANO, M. M.; MARAHIEL; M. A.; ZUBER, P. Identification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin in Bacillus subtilis. Journal Bacteriology, v. 170, p. 5662 - 5668, 1988.
NICOLETTI, G.; NICOLOSI, D.; ROSSOLINI, G. M. Eziologia, epidemiologia e diagnostic microbiologica delle infezion iintraddominali. Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance issues. Journal Le Infezioni in Medicina, v.1, 2008.
PAPAPARASKEVAS, J.; KATSANDRI, A.; PANTAZATOU, A.; STEFANOU, I.; AVLAMIS, A.; LEGASKIS, N. J.; TSAKRIS, A. Epidemiological characteristics of infections caused by Bacteroides, Prevotella and Fusobacterium species: a prospective observacional study. Anaerobe, v. 3; p. 113 - 117, 2011.
RIBEIRO-RIBAS, R. N.; VIEIRA, M. A. R.; APOLONIO, C. A.; MAGALHAES, P. P.; OLIVEIRA, J. S.; FARIAS, L. M. Purification and partial characterization of a bacteriocin produced by an oral Fusobacterium nucleatum isolated. Journal of Applied Microbiology, v. 7, p. 145 - 152, 2009.
ROELOFS, K. G.; COYNE, M. J.; GENTYALA, R. R.; CHATZIDAKI-LIVANIS, M.; COMSTOCK, L. E. Bacteroidales secreted antimicrobial proteins target surface molecules necessary for gut colonization and mediate competition in vivo. MBio, v. 7, p. 1055 - 1066, 2016.
SHEVCHENKO, A. et al. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Analytical Chemistry., v. 68, p. 850 - 858, 1996.
STEERS, E.; FOLTZ, E.; GRAVES, B. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antimicrobial Agents and Chemotherapy, v. 9, p. 307 - 311, 1959.
VALEFF, Carolina Nicolai. Atividade antagonista de extrato intracelular obtido de Fusobacterium necrophorum: modo de ação e caracterização bioquímica. 2011. 144f. Dissertação (Mestrado em Ciências Biológicas – Microbiologia) – Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 2011.
WEXLER, A. G.; BAO, Y.; WHITNEY, J. C.; BOBAY, L. M.; XAVIER, J. B.; SCHOFIELD, W. B. Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proceedings of the National Academy of Sciences of the United States of America, 2016.
WILSON, M. M.; ANDERSON, D. E.; BERNSTEIN, H. D. Analysis of the Outer Membrane Proteome and Secretome of Bacteroides fragilis Reveals a Multiplicity of Secretion Mechanisms. PLoS ONE, v. 10, 2015.
Relative intensity versus mass-on-charge function (m / z). Producing strain: Bacteroides fragilis D 111.4. Left: Fraction 2C, obtained on C8 column reverse phase chromatography. Right: strain extracted from gel and digested with trypsin.
